Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,433 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

NCT00788931

Conditions
Breast Diseases, Breast Neoplasms, HER-2 Positive Breast Cancer, +5 more
Locations
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Woodville, South Australia, Australia
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Liège, Belgium
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details
Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

NCT00958971

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Comprehensive Blood and Cancer Center Dept CBCC (3) Bakersfield, California, United States
  • Tower Cancer Research Beverly Hills, California, United States
  • UCLA/ University of California Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
  • Cancer Care Associates Medical Group Dept. of CCA Redondo Beach, California, United States
View all 38 locations
View Trial Details
Completed

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

NCT00526045

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UCLA/ University of California Los Angeles UCLA Los Angeles, California, United States
  • Georgia Health Sciences University Med College of GA Augusta, Georgia, United States
  • Dana Farber Cancer Institute StudyCoordinator:CAUY922A2101 Boston, Massachusetts, United States
  • Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. St Louis, Missouri, United States
View Trial Details
Completed

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

NCT01338831

Conditions
Breast Diseases, Breast Neoplasms, Castration-resistant Prostate Cancer, +19 more
Locations
  • Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States
  • Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States
  • Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States
View Trial Details
Completed

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

NCT02222922

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details
Completed

Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

NCT02088684

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Alabama at Birmingham/ Kirklin Clinic Dept Onc Birmingham, Alabama, United States
  • Dana Farber Cancer Institute Onc. Dept. Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States
  • Novartis Investigative Site Lyon, France
View Trial Details
Completed

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

NCT00600275

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States
View Trial Details

Related conditions